ATLAS News · Earnings

Elevance Health Reaffirms 2026 Adjusted EPS Outlook of at Least $29

Published November 10, 2026 · 6 sources

Elevance Health (ELV) expects to reaffirm its 2026 adjusted earnings guidance of at least $29 per diluted share, according to an SEC filing.

What happened

Elevance Health (ELV) said it expects to reaffirm its 2026 outlook, according to reports from Stock Titan, Moomoo, TradingView, TipRanks and GuruFocus. The company's adjusted earnings guidance for the year is at least $29 per diluted share.

Stock Titan reports that the outlook comes with about $7 a share in net unfavorable items. It adds that the guidance excludes any further adjustment items beyond those already reported in the third quarter of 2026. Moomoo cites an SEC filing as the source of the guidance.

Separately, Simply Wall St published a piece on the stock that references a fraud billing lawsuit.

Context

Adjusted earnings per share is a measure companies use to exclude certain items they consider outside their regular operations.

Why it matters

Reaffirmed guidance gives market participants a reference point for the company's expected full-year profitability.

Stocks in this story

Price changes are shown for the trading day of the story and are a coincidence in time, not proof that the news caused them. Figures are ATLAS data from our database.

Elevance HealthELV

+2.73%

Healthcare · NYSE

Live price

$429.90▲ +2.73%

live price · USD

Close on November 10: $429.65+2.73% vs. previous close ($418.25)
Fair value (ATLAS): $544.59Fair range: $490.13 to $599.05The price ($429.90) is 21.1% below that figure.
Chance of a rise in 1 month: 51%Probability of closing higher than today within 21 sessions.Normal range: half of the scenarios end between $410.17 and $452.76; 9 in 10, between $375.77 and $494.20.

See the full ATLAS analysis of Elevance Health →

Closing prices, fair value and probabilities: ATLAS own data. How we calculate fair value.

Sources

ATLAS writes its own summaries from the reporting of these outlets. Each link opens the original publisher.

With about $7 a share in net unfavorable items, Elevance Health (ELV) expects to reaffirm its 2026 outlook. · Stock Titan · November 10, 2026
ELEVANCE HEALTH - EXPECTS FY2026 ADJ EARNINGS OF AT LEAST $29 PER DILUTED SHARE - SEC FILING · Moomoo · November 10, 2026
Elevance Health - Expects Fy2026 Adjusted Earnings Of At Least $29 Per Diluted Share · TradingView · November 10, 2026
Elevance Health Officers to Reaffirm 2026 Earnings Guidance · TipRanks · November 10, 2026
Elevance Health (ELV) Reaffirms 2026 Earnings Guidance of at Lea · GuruFocus · November 11, 2026
Elevance Health (ELV) Stock Still Looks Reasonable On Fraud Billing Lawsuit · Simply Wall St · November 11, 2026

Latest market news · Markets today on ATLAS · Elevance Health

What you get with ATLAS

Create my ATLAS account →

Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.

Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer